Advancing Precision Nutrition: Wearable Technology for Noninvasive Insulin Monitoring

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-90
SponsorTexas A&M University

About this trial

Noninvasively monitoring insulin is crucial for advancing precision nutrition and promoting healthy living by enabling a deeper understanding of individual metabolic responses to dietary intake. Insulin is a key regulator of blood sugar and energy metabolism, and its dysregulation is linked to conditions such as diabetes, obesity, and metabolic syndrome. By noninvasively tracking insulin levels, individuals can gain real-time insights into how their body processes different foods, allowing for the personalization of diets to optimize metabolic health, manage weight, and reduce disease risk. This approach also empowers proactive lifestyle adjustments to maintain insulin sensitivity, improve glycemic control, and enhance overall well-being. Decentralized insulin quantification in biofluids, including saliva and serum, based on lateral flow assay or electrochemical sensor has been reported. However, these approaches have poor sensitivity and fail to quantify insulin with a high temporal resolution.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age

● 18-30 years old

● 50-90 years old

BMI between 18 and 35 kg/m2

Disqualifiers

Known allergy to any of the components of the meal or agents used for the application of the devices

Sunflower oil

Maltodextrin

Whey protein

Trial design

Design model

Single group

Treatments tested in this trial

  • Standardized meal 1

    Other intervention

    Meal contains Whey powder (60g) as protein, Maltodextrin (Polycose; 170g) as carbohydrate, and Sunflower Oil (48g) as the fat source. The meal is mixed and flavored using vanilla sugar-free instant pudding.

Treatment groups

32 Participants
are divided into 1 treatment group
Group A: Standardized liquid meal drinkExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Quantification of protein biomarkers

Time-varying plasma insulin concentrations and correlation between sweat and dermal interstitial fluid.

Time frame
up to 9 hours, 1 day

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.